Is Piperacillin and Tazobactam Injection in shortage?
Piperacillin and Tazobactam Injection is listed by FDA as being discontinued by at least one maker (updated Jan 20, 2026).
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Piperacillin and Tazobactam, Injection, 2.25 g vial (NDC 65219-434-20)
Discontinuation of the manufacture of the drug
Maker contact: 888-386-1300
FDA recalls of the same active ingredient
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Piperacillin and Tazobactam Injection:
- Merck Sharp & Dohme recalls Zerbaxa (ceftolozane and tazobactam) 1.5g per vial for injection, Single-Dose vial, Rx only, Manuf. for: Merck Sharp &
- AuroMedics Pharma LLC recalls Piperacillin and Tazobactam for Injection USP 3.375 grams per vial, Single-Dose Vial, Rx Only. Manufactured for:
- AuroMedics Pharma LLC recalls Piperacillin and Tazobactam for Injection, USP 3.375 grams per vial, For Intravenous Use Only, Single-Dose vial, Rx
Piperacillin and Tazobactam Injection shortage questions
Is Piperacillin and Tazobactam Injection in shortage?
Piperacillin and Tazobactam Injection is listed by FDA as being discontinued by at least one maker (updated Jan 20, 2026).
What should I do if I can’t get Piperacillin and Tazobactam Injection?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.